Longevity
Human data validate Cambrian Bio’s aging target
Positive Phase 1b results for ATX-304 suggest scientists may finally be able to restore a key metabolic pathway that declines with age. There are few ideas in aging biology that have generated as much excitement (and as much disappointment) as AMPK. Researchers have viewed this cellular pathway as one of the body’s most important regulators […] The post Human data validate Cambrian Bio’s aging target appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →